PE/FITC/APC/Biotin-Conjugated EGFRvIII Antibody for Cell Analysis

EGFR variant III (EGFRvIII) is a tumor-specific in-frame deletion mutant of EGFR expressed in glioblastoma but absent from normal tissues. EGFRvIII is a tumor-specific CAR-T target pioneered in glioblastoma clinical studies.

Order information

Catalog No.Product NameConjugateSizePrice (In USD)
GM-Tg-hg-T64969-Ab-3-PEAnti-Human EGFR vIII monoclonal antibody(mAb)(PE)PE25T
GM-Tg-hg-T64969-Ab-3-PEAnti-Human EGFR vIII monoclonal antibody(mAb)(PE)PE100T
GM-Tg-hg-T64969-Ab-3-PEAnti-Human EGFR vIII monoclonal antibody(mAb)(PE)PE500T
GM-Tg-hg-T64969-Ab-3-FITCAnti-Human EGFR vIII monoclonal antibody(mAb)(FITC)FITC25T
GM-Tg-hg-T64969-Ab-3-FITCAnti-Human EGFR vIII monoclonal antibody(mAb)(FITC)FITC100T
GM-Tg-hg-T64969-Ab-3-FITCAnti-Human EGFR vIII monoclonal antibody(mAb)(FITC)FITC500T
GM-Tg-hg-T64969-Ab-3-APCAnti-Human EGFR vIII monoclonal antibody(mAb)(APC)APC25T
GM-Tg-hg-T64969-Ab-3-APCAnti-Human EGFR vIII monoclonal antibody(mAb)(APC)APC100T
GM-Tg-hg-T64969-Ab-3-APCAnti-Human EGFR vIII monoclonal antibody(mAb)(APC)APC500T
GM-Tg-hg-T64969-Ab-3-BiotinAnti-Human EGFR vIII monoclonal antibody(mAb)(Biotin)Biotin25T, 100T, 500T

Description

TargetEGFRvIII (specific biomarker for human glioblastoma / EGFR+ tumor)
SpeciesHumanized
Expression platformMammalian cell
IsotypesHuman IgG
TaghFc
ConjugatePE / FITC / APC / Biotin
Size25T / 100T / 500T
Purity>=95% (SDS-PAGE)
Bioactivity validationEGFRvIII binding, FACS in EGFRvIII level test
ApplicationFACS and other Immunoassay for EGFRvIII test
Products descriptionAnti-Human EGFR vIII monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes EGFRvIII (EGFR variant III, a tumor-specific deletion mutant expressed on glioblastoma). EGFRvIII is a glioblastoma / EGFR+ tumor marker. This antibody is validated by FACS for glioblastoma target assessment for EGFRvIII CAR-T. It is recommended for multi-color flow cytometry panels to validate EGFRvIII expression for glioblastoma CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment.
Formulation & ReconstitutionLyophilized from sterile PBS, pH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.



<